Coldstream Capital Management Inc Aurinia Pharmaceuticals Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,611 shares of AUPH stock, worth $13,306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,611Holding current value
$13,306% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AUPH
# of Institutions
240Shares Held
62.7MCall Options Held
1.13MPut Options Held
1.25M-
Black Rock Inc. New York, NY9.27MShares$76.6 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA8.43MShares$69.6 Million5.69% of portfolio
-
Armistice Capital, LLC New York, NY6.4MShares$52.9 Million0.81% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32.8 Million3.03% of portfolio
-
State Street Corp Boston, MA2.85MShares$23.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.17B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...